AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 36 filers reported holding AXSOME THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 2.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $956 | -55.0% | 13,686 | -53.7% | 0.10% | -41.4% |
| Q2 2023 | $2,126 | +468.4% | 29,579 | +387.2% | 0.16% | +305.0% |
| Q1 2023 | $374 | -99.9% | 6,071 | -35.9% | 0.04% | +2.6% |
| Q3 2022 | $422,000 | +31.9% | 9,466 | +13.3% | 0.04% | +44.4% |
| Q2 2022 | $320,000 | -52.2% | 8,355 | -58.8% | 0.03% | -54.2% |
| Q3 2021 | $669,000 | +99.1% | 20,292 | +241.6% | 0.06% | +145.8% |
| Q1 2021 | $336,000 | -61.7% | 5,940 | -51.8% | 0.02% | -84.1% |
| Q3 2020 | $878,000 | +78.5% | 12,320 | +105.9% | 0.15% | +164.9% |
| Q2 2020 | $492,000 | +720.0% | 5,984 | -67.8% | 0.06% | +1800.0% |
| Q2 2018 | $60,000 | – | 18,609 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 758,794 | $53,032,113 | 65.14% |
| Fairmount Funds Management LLC | 2,341,238 | $163,629,124 | 19.69% |
| Ally Bridge Group (NY) LLC | 110,600 | $7,729,834 | 9.07% |
| RTW INVESTMENTS, LP | 4,489,596 | $313,777,864 | 6.62% |
| SVB FINANCIAL GROUP | 33,849 | $2,365,707 | 4.45% |
| BVF INC/IL | 2,131,100 | $148,942,579 | 4.02% |
| Altium Capital Management LP | 92,000 | $6,429,880 | 3.35% |
| Tri Locum Partners LP | 142,510 | $9,960,024 | 3.18% |
| TANG CAPITAL MANAGEMENT LLC | 320,000 | $22,364,800 | 3.16% |
| Deep Track Capital, LP | 1,140,745 | $79,726,668 | 3.08% |